Approximately 14 million people within the WHO EU Region are chronically infected with Hepatitis B.1 TAF is an investigationaltreatmentfor HBV and is approved as a component of a fixed-dose combination (Genvoya, E/C/F/TAF) for HIV infection. TDF is an approved treatment option for both HIV ...